Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,438 | 191 | 99.3% |
| Education | $29.95 | 4 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,635 | 70 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $545.16 | 29 | $0 (2023) |
| Lilly USA, LLC | $363.57 | 20 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $342.19 | 15 | $0 (2023) |
| Amgen Inc. | $247.27 | 11 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $232.44 | 6 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $193.19 | 8 | $0 (2018) |
| Medtronic MiniMed, Inc. | $179.08 | 4 | $0 (2018) |
| Amarin Pharma Inc. | $163.36 | 4 | $0 (2020) |
| AbbVie Inc. | $162.69 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $117.94 | 6 | Lilly USA, LLC ($43.48) |
| 2022 | $171.72 | 9 | Bayer HealthCare Pharmaceuticals Inc. ($82.06) |
| 2021 | $136.44 | 9 | Kowa Pharmaceuticals America, Inc. ($38.92) |
| 2020 | $295.67 | 12 | Novo Nordisk Inc ($119.82) |
| 2019 | $640.78 | 34 | Novo Nordisk Inc ($432.91) |
| 2018 | $1,089 | 47 | Novo Nordisk Inc ($423.12) |
| 2017 | $2,016 | 78 | Novo Nordisk Inc ($591.91) |
All Payment Transactions
195 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/26/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Cardiology | ||||||
| 09/12/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: Diabetes | ||||||
| 05/04/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: DIABETES | ||||||
| 04/20/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Diabetes | ||||||
| 03/16/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Diabetes | ||||||
| 02/02/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Respiratory | ||||||
| 12/01/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $31.58 | General |
| Category: Cardio-renal | ||||||
| 12/01/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $30.37 | General |
| Category: Cardio-renal | ||||||
| 10/27/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Respiratory | ||||||
| 10/20/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: Cardio-renal | ||||||
| 10/06/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/29/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Diabetes | ||||||
| 06/16/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: Diabetes | ||||||
| 06/10/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Seglentis | Food and Beverage | Cash or cash equivalent | $12.84 | General |
| Category: Cardiovascular | ||||||
| 05/05/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Respiratory | ||||||
| 11/04/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Respiratory | ||||||
| 09/30/2021 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: Neuroscience | ||||||
| 09/16/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Diabetes | ||||||
| 09/09/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $15.05 | General |
| Category: Cardiovascular | ||||||
| 08/31/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $11.72 | General |
| Category: Cardiovascular | ||||||
| 07/22/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/22/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $12.15 | General |
| Category: Cardiovascular | ||||||
| 02/12/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Diabetes | ||||||
| 09/10/2020 | Lilly USA, LLC | BASAGLAR (Drug), TRULICITY, JARDIANCE | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 2,323 | 4,066 | $472,019 | $170,714 |
| 2022 | 26 | 2,215 | 3,773 | $399,013 | $143,636 |
| 2021 | 23 | 1,951 | 3,698 | $357,427 | $134,189 |
| 2020 | 22 | 1,838 | 3,375 | $265,817 | $108,328 |
All Medicare Procedures & Services
100 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 175 | 537 | $174,525 | $57,869 | 33.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 147 | 147 | $50,421 | $22,413 | 44.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 130 | 130 | $20,338 | $9,351 | 46.0% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 92 | 296 | $23,088 | $8,971 | 38.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 98 | 132 | $29,700 | $8,904 | 30.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 31 | 36 | $15,660 | $5,570 | 35.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 150 | 153 | $7,956 | $5,505 | 69.2% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 59 | 59 | $14,809 | $5,393 | 36.4% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 173 | 173 | $13,494 | $5,332 | 39.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 26 | 26 | $16,302 | $4,922 | 30.2% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 167 | 167 | $9,185 | $3,665 | 39.9% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 48 | 84 | $12,600 | $3,593 | 28.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 159 | 159 | $8,745 | $3,489 | 39.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 47 | 65 | $9,035 | $3,086 | 34.2% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 21 | 21 | $5,880 | $2,747 | 46.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 14 | 14 | $6,846 | $2,738 | 40.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 14 | 14 | $7,028 | $2,732 | 38.9% |
| 81002 | Urinalysis, manual test | Office | 2023 | 185 | 641 | $4,487 | $2,159 | 48.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 105 | 257 | $4,626 | $2,108 | 45.6% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2023 | 28 | 29 | $6,675 | $2,074 | 31.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 158 | 167 | $8,851 | $1,970 | 22.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 42 | 138 | $8,970 | $1,718 | 19.2% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 19 | 19 | $3,914 | $1,268 | 32.4% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 123 | 387 | $3,483 | $1,242 | 35.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 21 | 21 | $1,050 | $755.58 | 72.0% |
About Dr. Joseph Dic, D.O
Dr. Joseph Dic, D.O is a Family Medicine healthcare provider based in Deer Park, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376569707.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Dic, D.O has received a total of $4,468 in payments from pharmaceutical and medical device companies, with $117.94 received in 2023. These payments were reported across 195 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($4,438).
As a Medicare-enrolled provider, Dic has provided services to 8,327 Medicare beneficiaries, totaling 14,912 services with total Medicare billing of $556,867. Data is available for 4 years (2020–2023), covering 100 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Deer Park, NY
- Active Since 07/15/2006
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1376569707
Products in Payments
- Ozempic (Drug) $641.34
- FARXIGA (Drug) $455.94
- JARDIANCE (Drug) $441.53
- Victoza (Drug) $415.95
- Xultophy 100/3.6 (Drug) $266.46
- ENTRESTO (Drug) $232.44
- Tresiba (Drug) $194.36
- iPro2 (Device) $179.08
- TRULICITY (Drug) $171.69
- INVOKANA (Drug) $166.05
- Vascepa (Drug) $163.36
- Repatha (Biological) $148.74
- Livalo (Drug) $142.78
- Synthroid (Drug) $141.52
- Kerendia (Drug) $82.06
- Aimovig (Biological) $79.03
- BREZTRI (Drug) $62.10
- Levemir (Drug) $56.98
- Rybelsus (Drug) $52.92
- TRADJENTA (Drug) $47.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Deer Park
Behrouz Farahmandpour, D.o, D.O
Family Medicine — Payments: $30,635
Francine Dimaria, D.o, D.O
Family Medicine — Payments: $9,445
Dr. Edwardo Yambo, Md, MD
Family Medicine — Payments: $7,067
Dr. Basil Griffin, M.d, M.D
Family Medicine — Payments: $5,527
Dr. Marc Lewandoski, Do, DO
Family Medicine — Payments: $4,031
Dr. Julie Moran, M.d, M.D
Family Medicine — Payments: $3,539